Heizmann W, Heilmann F, Werner H
Abteilung für Medizinische Mikrobiologie, Hygiene-Institut der Universität, Tübingen.
Infection. 1987;15(5):370-4. doi: 10.1007/BF01647747.
The antimicrobial susceptibility of 195 recent clinical isolates of anaerobic bacteria was studied to ampicillin alone, ampicillin + 1 mg/l sulbactam, ampicillin + 5 mg/l sulbactam, and cefoxitin by means of agar dilution tests. The ampicillin-sulbactam combinations were the most effective drugs against species of the Bacteroides fragilis group, the MIC90 of ampicillin + 5 mg/l sulbactam for B. fragilis being less than 1 mg/l, compared to 256 mg/l of ampicillin, 4 mg/l of ampicillin + 1 mg/l sulbactam, and 8 mg/l of cefoxitin. No significant difference between ampicillin alone and in combination with sulbactam was observed against gram-positive anaerobic rods, Peptococcus spp. and Peptostreptococcus spp. with MIC's less than 2 mg/l.
采用琼脂稀释法,对195株近期临床分离的厌氧菌进行了单独氨苄西林、氨苄西林+1mg/L舒巴坦、氨苄西林+5mg/L舒巴坦及头孢西丁的药敏试验。氨苄西林-舒巴坦联合制剂是针对脆弱拟杆菌群最有效的药物,氨苄西林+5mg/L舒巴坦对脆弱拟杆菌的MIC90小于1mg/L,相比之下,氨苄西林的MIC90为256mg/L,氨苄西林+1mg/L舒巴坦为4mg/L,头孢西丁为8mg/L。对于MIC小于2mg/L的革兰氏阳性厌氧杆菌、消化球菌属和消化链球菌属,未观察到单独氨苄西林与氨苄西林-舒巴坦联合制剂之间存在显著差异。